CEFTACAB S 1.5GM INJECTION :CEFTRIAXONE 1gm. IP + SULBACTAM 500mg. IP

Ceftacab S 1.5GM Injection is a ceftriaxone plus sulbactam injection used against susceptible bacterial infections. Main uses: lower respiratory tract infections caused by susceptible bacteria; acute bacterial otitis media (middle ear infection) caused by susceptible bacteria; skin and skin structure infections caused by susceptible bacteria; intra-abdominal infections caused by susceptible bacteria; gynaecological infections caused by susceptible bacteria.

Common side effects of Ceftacab S 1.5GM Injection include pain, redness, swelling or hardness at the injection site; phlebitis or warmth along the vein after intravenous use; rash; diarrhoea or loose stools; nausea or vomiting; raised liver enzyme levels in blood tests. Get medical help at once if you notice severe allergic reactions, including anaphylaxis; severe skin reactions; pseudomembranous colitis (severe diarrhoea during or after antibiotic use).

Ceftacab S 1.5GM Injection contains Ceftriaxone 1 g + Sulbactam 500 mg. Ceftacab S 1.5GM Injection is given by a doctor or nurse, who decides the dose and how often it is given.

The MRP of Ceftacab S 1.5GM Injection is ₹190 for a pack of 1.5gm. For chemists and distributors, the PTR is ₹144.76 and the PTS is ₹130.29.

Ceftacab S 1.5GM Injection contains Ceftriaxone 1 g + Sulbactam 500 mg. It comes in a pack of 1.5gm.

Ceftriaxone is a cephalosporin antibiotic that disturbs the building of the bacterial cell wall, leaving the bacteria unable to survive and multiply. Sulbactam is a beta-lactamase inhibitor that blocks the enzymes produced by some bacteria to break down antibiotics, and by doing so it supports the action of Ceftriaxone against those bacteria.

Must not be used by anyone with a known allergy to ceftriaxone, sulbactam or any other cephalosporin. Must not be used by anyone with a history of a serious hypersensitivity reaction (such as anaphylaxis or Stevens-Johnson syndrome) to other beta-lactam antibiotics. Must not be used in premature newborn babies up to a post-menstrual age of 41 weeks. Must not be used in newborn babies with high bilirubin (jaundice). Must not be used in newborn babies who need calcium-containing intravenous fluids, and check with a doctor first if you have had an allergy to penicillins, kidney or liver problems, a history of antibiotic-related colitis, or if you are pregnant or breastfeeding.

Ceftacab S 1.5GM Injection is a brand of Vibcare Pharma, sold through its Medanor division. It is available for PCD pharma franchise and distribution in India; use the Send Enquiry or WhatsApp button on this page to ask about availability and terms.